Chemo Pharma Laboratories Ltd. - Research Center
506365 CHEMOPH Group (X) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
Share application money
Preference share capital
Reserves & surplus
10.10 |
10.05 |
9.49 |
9.24 |
8.83 |
Secured loans
Unsecured loans
Total
11.60 |
11.55 |
10.99 |
10.74 |
10.33 |
Gross block
Less : revaluation reserve
Less : accumulated depreciation
Net block
Capital work-in-progress
Investments
Current assets, loans & advances
8.57 |
8.68 |
10.96 |
10.87 |
10.38 |
Less : current liabilities & provisions
Total net current assets
8.55 |
8.57 |
10.90 |
10.65 |
10.29 |
Miscellaneous expenses not written
Total
11.60 |
11.55 |
10.99 |
10.74 |
10.33 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
15.00 |
15.00 |
15.00 |
15.00 |
15.00 |